**Background:** Schobinger stage 4 facial arteriovenous malformations (AVMs) are life-threatening lesions that cause severe disfigurement, pain, bleeding, and psychological distress. Standard management involves a multimodality approach: preoperative devascularization, skeletonization, and deafferentation (DSD) by interventional radiologists, wide radical excision by vascular surgeons within 48–72 hours, and reconstruction by plastic surgeons. Recurrence is a major challenge, attributed to ischemia-induced parasitization and recruitment of mesodermal vascular residuum. The "regulating free flap effect"—introduction of well-vascularized tissue to suppress ischemia and prevent recurrence—has been proposed. This study evaluates an algorithmic approach using microvascular free flaps for reconstruction after excision of stage 4 facial AVMs, focusing on recurrence prevention, choice of recipient vessels, and need for secondary procedures.
**Methods:** This retrospective cohort study was conducted from March 2015 to March 2021 at a single institution. Inclusion criteria: all patients with Schobinger stage 4 facial AVMs who underwent wide excision and microvascular free flap reconstruction. Exclusion criteria: inability to follow up or concurrent intracranial AVM extension. Sixteen patients (12 males, 4 females; average age 43 years) were included. All had associated systemic effects: chronic disseminated intravascular coagulopathy (DIC) (n=16), intermittent pulsatile bleeding (n=5), high-output cardiac failure (n=4), uncontrolled hypertension (n=4), diabetes mellitus (n=2), and polycystic kidney disease (n=1). Preoperative strategies included DSD using coaxial superselective catheterization and embolization of perinidus feeders, hematological optimization (fresh whole blood, platelets, fresh-frozen plasma, vitamin K, steroids, epsilon aminocaproic acid), cardiological optimization, and culture-directed antibiotics for 10–15 days. Operative strategies involved proximal vascular control (ipsilateral or contralateral external carotid artery), wide radical excision through uninvolved penumbra, and microvascular free flap reconstruction using penumbral feeder vessels as recipients (superficial temporal vessels in 87.5%, facial vessels in 12.5%). Postoperative management included invasive monitoring, pressor support, no heparinization, and early ambulation after 48 hours. Patients were screened at 6, 18, and 24 months with high-resolution ultrasonography and clinical examination. Aesthetic and functional outcomes were assessed at 12 months using an institutional score (4–16 points; grades: poor 12–16, fair-to-good 8–12, good-to-excellent 4–8). Recurrence was compared retrospectively to 14 age- and sex-matched controls (6 pedicled flaps, 8 skin grafts) using multiple regression analysis and chi-squared test.
**Key Results:** The average postexcisional defect size was 75.18 cm², and average flap size was 113.43 cm². Twelve patients received anterolateral thigh free flaps, three transverse rectus abdominis free flaps, and one primarily thinned radial forearm free flap. All 16 flaps survived; one flap (6.25%) had venous congestion at 48 hours, requiring exploration and revision venous anastomosis, after which it survived uneventfully. Two patients (12.5%) developed lower lid ectropion by 6 months, requiring secondary procedures (fascia lata sling and blepharoplasty). Fifteen patients (93.75%) had pre-excisional DSD; one (6.25%) had intralesional sclerotherapy. Four patients (25%) required secondary fascia lata sling and blepharoplasty. Twelve patients (75%) with preoperative congestive cardiac failure recovered completely postoperatively. Thirteen patients (81.25%) had ulceration and bleeding episodes; all 16 (100%) had hematological/coagulation derangements that corrected postoperatively. At average follow-up of 18.5 months, 0% had locoregional recurrence. Fourteen patients (87.5%) achieved good-to-excellent aesthetic/functional scores (p=0.035); two (12.5%) had fair results. Compared to controls, free flaps had 0% recurrence versus 64% in pedicled flaps and skin grafts (p=0.035, chi-squared test).
**Clinical Implications:** This study demonstrates that microvascular free flap reconstruction after wide excision of Schobinger stage 4 facial AVMs effectively prevents recurrence, likely due to the "regulating free flap effect"—the homogenized supranormal blood supply suppresses ischemia-induced parasitization and recruitment of mesodermal vascular residuum. The successful use of penumbral feeder vessels as recipient vessels (with only one venous complication salvaged) challenges previous concerns about thrombosis and supports their safety with diligent microvascular technique. The multidisciplinary protocol (DSD, hematological/cardiological optimization, wide excision, free flap reconstruction) yielded high flap survival (100%), excellent aesthetic/functional outcomes (87.5% good-to-excellent), and resolution of systemic effects (e.g., cardiac failure, coagulopathy). Limitations include small sample size and retrospective design. Future research should include larger prospective studies and longer follow-up to confirm these findings.